LOXO LARO 25 mg (Vitrakvi 25 mg)
Generic Name: larotrectinib
Pill with imprint LOXO LARO 25 mg is White, Capsule-shape and has been identified as Vitrakvi 25 mg. It is supplied by Loxo Oncology, Inc..
Vitrakvi is used in the treatment of solid tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOXO LARO 25 mg
More about Vitrakvi (larotrectinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: multikinase inhibitors
- FDA Approval History
- Patient Information
- Vitrakvi (Advanced Reading)
- Vitrakvi (Larotrectinib Capsules)
- Vitrakvi (Larotrectinib Oral Solution)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.